These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis]. Paskhina TS; Poliantseva LR; Platonova LV; Levina GO Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275 [TBL] [Abstract][Full Text] [Related]
5. Measurement of urinary kallikrein acitvity by kinin radioimmunoassay. Shimamoto K; Tanaka S; Nakao T; Ando T; Nakahashi Y; Sakuma M; Miyahara M Jpn Circ J; 1979 Mar; 43(3):147-52. PubMed ID: 109645 [TBL] [Abstract][Full Text] [Related]
6. Strategy of measuring bradykinin and kallidin and their concentration in plasma and urine. Hilgenfeldt U; Linke R; Riester U; König W; Breipohl G Anal Biochem; 1995 Jun; 228(1):35-41. PubMed ID: 8572285 [TBL] [Abstract][Full Text] [Related]
7. Aspects of bradykinin radioimmunoassay. Odya CE; Goodfriend TL; Stewart JM; Peña C J Immunol Methods; 1978; 19(2-3):243-57. PubMed ID: 624845 [TBL] [Abstract][Full Text] [Related]
8. Kinin excretion in urine in normal adults and patients with essential hypertension determined by an enzymeimmunoassay. Stahr K; Hubl W; Scheuch DW Exp Clin Endocrinol; 1988 Sep; 92(1):106-10. PubMed ID: 3068064 [TBL] [Abstract][Full Text] [Related]
9. Kinins in humans. Duncan AM; Kladis A; Jennings GL; Dart AM; Esler M; Campbell DJ Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R897-904. PubMed ID: 10749777 [TBL] [Abstract][Full Text] [Related]
10. [The response of the airways in asthmatic patients to kinin inhalations define a type-B2 receptor profile]. Polosa R; Cacciola RR; Holgate ST Ann Ital Med Int; 1992; 7(4):220-5. PubMed ID: 1338489 [TBL] [Abstract][Full Text] [Related]
11. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man. Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266 [TBL] [Abstract][Full Text] [Related]
12. Development of a radioimmunoassay for [DES-ARG9]-bradykinin. Odya CE; Moreland P; Stewart JM; Barabe J; Regoli DC Biochem Pharmacol; 1983 Jan; 32(2):337-42. PubMed ID: 6870961 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the actions of kallidin and bradykinin in the skin of normal and psoriatic subjects. Marshman G; Burton JL; Archer CB Clin Exp Dermatol; 1996 Mar; 21(2):112-5. PubMed ID: 8759196 [TBL] [Abstract][Full Text] [Related]
14. Urinary excretions of kininase I and kininase II activities in essential hypertension. A sensitive and simple method for its kinin-destroying capacity. Ura N; Shimamoto K; Tanaka S; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O J Clin Hypertens; 1985 Mar; 1(1):15-22. PubMed ID: 3014073 [TBL] [Abstract][Full Text] [Related]
15. Determination of human urinary kinin levels by radioimmunoassay using a tyrosine analogue of bradykinin. Mashford ML; Roberts ML Biochem Pharmacol; 1971 May; 20(5):969-73. PubMed ID: 5168394 [No Abstract] [Full Text] [Related]
16. Application of bradykinin radioimmunoassay for the measurement of urinary kallikrein activity rats. Stocker M; Hornung J Klin Wochenschr; 1978; 56 Suppl 1():127-9. PubMed ID: 732246 [TBL] [Abstract][Full Text] [Related]
17. [Plasma bradykinin concentration in patients with cardiovascular diseases]. Minami M; Togashi H; Sano M; Endoh T; Saito H; Hashimoto F; Fujita K; Yasuda H; Kuriyamoto Y; Nishino T Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):159-69. PubMed ID: 6363231 [TBL] [Abstract][Full Text] [Related]
18. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. Scicli AG; Mindroiu T; Scicli G; Carretero OA J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569 [TBL] [Abstract][Full Text] [Related]